A randomized, double-blind, placebo controlled phase III study in patients with metastatic adenocarcinoma of the colon or rectum receiving first line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222 584 or placebo (CONFIRM-1). - Hecht,R.; Trarbach,T.; Jaeger,E.; Hainsworth,R. (Proc Am Soc Clin Oncol, 2005)